Troutman Pepper advised Innervace on the deal. Innervace, a regenerative medicine company developing the first implantable biofabricated neural pathway to restore brain circuitry, announced its $40...
Troutman Pepper advised Innervace on the deal. Innervace, a regenerative medicine company developing the first implantable biofabricated neural pathway to restore brain circuitry, announced its $40...
